Saturday 17 October 2026
Export DHR’s income statement to Excel — free account
Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.
228.97
2.53
−1.09%
Follow DHR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
6.84% | 7.08% | 7.11% | 7.63% | |
Piotroski F-Score |
7 | 6 | 6 | 6 | |
| 4.36% | 4.49% | 4.54% | 4.60% | ||
ROIC |
4.34% | 4.42% | 4.59% | 4.37% | |
Return on Tangible Assets |
40.46% | 31.48% | 30.89% | 36.07% | |
Average Days of Receivables |
56.48 | 58.13 | 56.26 | 57.64 | |
Free Cash Flow per Share |
7.07 | 7.43 | 7.51 | 7.78 | |
Free Cash Flow |
5,028.00 | 5,293.00 | 5,318.00 | 5,489.00 | |
Capital Expenditures |
(1,290.00) | (1,123.00) | (1,121.00) | (1,146.00) | |
| Other line items | |||||
Cash ROIC |
7.24% | 7.00% | 6.98% | 6.69% | |
Accounts Receivable Turnover |
6.68 | 6.60 | 6.77 | 6.67 | |
Accounts Payable Turnover |
5.96 | 5.59 | 5.79 | 5.87 | |
Inventory Turnover |
3.67 | 4.17 | 3.96 | 3.50 | |
Average Days of Payables |
63.11 | 67.00 | 64.21 | 63.85 | |
Days of Inventory on Hand |
99.38 | 90.44 | 93.55 | 114.24 | |
Tax Rate |
(0.16) | (0.15) | (0.15) | (0.16) | |
Research and Development Expense of Revenue |
6.60% | 6.50% | 6.48% | 6.43% | |
Selling, General and Administrative Expense of Revenue |
33.92% | 33.52% | 33.24% | 31.66% | |
Share Based Compensation of Revenue |
1.20% | 1.21% | 1.19% | 1.18% | |
Interest Coverage |
17.02 | 17.70 | 18.59 | 17.56 | |
Operating CF/Net income |
1.80 | 1.78 | 1.75 | 1.66 | |
Depreciation/Fixed assets |
0.45 | 0.44 | 0.45 | 0.44 | |
Capex/Depreciation |
(0.53) | (0.46) | (0.45) | (0.44) | |
Revenue per Share |
34.15 | 34.47 | 35.00 | 35.60 | |
Operating CF per Share |
8.89 | 9.00 | 9.10 | 9.41 | |
Capex per Share |
(1.82) | (1.58) | (1.58) | (1.62) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 |
Columns are period end dates